Match Document Document Title
4801532 Immunological methods for diagnosing neurocysticercosis  
Immunological methods are disclosed for diagnosing active human neurocysticercosis, including a serum test and a cerebrospinal fluid test. The serum test involves detecting an antibody in serum...
4801691 Method for removing sodium dodecyl sulfate from sodium dodecyl sulfate solubilized protein solutions  
Guanidine hydrochloride (GCl) is used to remove excess sodium dodecyl sulfate (SDS) from SDS-solubilized protein solutions, and particularly from SDS-solubilized inclusion body solutions, GCl is...
4801686 Purification of recombinant interleukin-1  
A process is provided for purifying recombinant IL-1 from microbial cells, comprising suspending the cells in an aqueous buffered medium having a pH from about 1 to about 5; disrupting the cells to...
4797474 Solubilization of protein aggregates  
A method for the recovery of proteins which method includes providing a source of protein in an insoluble form, a source of at least one cationic surfactant; treating the insoluble protein with the...
4795804 Bone morphogenetic agents  
The production and isolation of bone morphogenetic peptide agents displaying the osteoinductive and immunoreactive activity of bone morphogenetic protein (BMP) and deriving from natural, synthetic...
4794171 Calcium-phosphate type hydroxyapatite and process for producing same  
A calcium-phosphate type hydroxyapatite which belongs to a series of hexagonal systems has unit lattice constants of 9.58±0.08 Å for the a axis and 7.00±0.05 Å for the c axis. Its Ca/P ratio...
4794077 Detection of human cancer cells with anitbodies to human cancer nucleolar antigen p145  
Specific common nucleolar antigens are found in a broad range of human malignant tumor specimens and have been isolated, extracted and purifed. Monoclonal antibodies specific to one of these...
4789732 Bone morphogenetic protein composition  
BMP compositions including the human factor and bovine factor thereof, the process of isolating BMP compositions and factors, and the use of such factors and compositions to induce bone formation...
4788056 Combined vaccine for viral and bacterial infections  
Vaccines containing both E.coli and herpes virus were found not to provide adequate protection against subsequent herpes virus infections. The present invention is concerned with a E.coli herpes...
4786501 Cylindrical implants for the controlled release of growth hormones  
This invention relates to a method for purifying and concentrating biologically active growth hormone to produce growth hormone in a form suitable for incorporation into a controlled release device...
4784589 Purification of pertussis antigens  
A process is provided for the production of lymphocytosis promoting factor (LPF), filamentous haemagglutinin (FHA) and at least one fimbrial agglutinogen from a liquid culture of Bordetella...
4782027 Protein detection by negative staining  
A polypeptide is located in a gel matrix by treating the matrix with a negative staining agent (i.e. an agent that stains the gel more intensely in regions devoid of polypeptides, so that gel areas...
4778846 Affinity chromatography sorbent  
A novel process for the isolation and purification of vancomycin class antibiotics which utilized affinity chromatography by the formation of a sorption complex between the antibiotic and an...
4777241 Proteinaceous substance showing antitumorous action and its preparing method  
A proteinaceous substance having the following biochemical characteristics: (A) a strong cytolytic activity against mouse tumor cells L-929, but not cytotoxic activity for normal cells such as...
4777242 Purification of recombinant tumor necrosis factor  
A method for purifying recombinant tumor necrosis factor from cultures of microorganisms transformed with vectors that code for the production of tumor necrosis factor is disclosed. A sequence of...
4774323 Purification of von Willebrand Factor solutions using gel permeation chromatography  
A method of preparing von Willebrand Factor by disassociating it from a chaotropic agent in solution therewith and preferably treating the same under controlled temperature either in liquid or...
4774086 Process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the Bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine  
A method for the purification, solubilization and/or detoxification of protein antigens of bacteria of the Bordetella genus involves the use of a carbonate buffer having a pH of 8.3 to 11.6. An...
4772397 Process for removing nucleic acids and purine bases from gelatin  
The invention relates to a process for removing nucleic acids and purine bases from gelatine by (a) adding cyclodextrin bead polymer having a particle size of 20 to 600 μ, a cyclodextrin content...
4771125 Human soluble immune response suppressor  
Human soluble immune response suppressor (SIRS) having a molecular weight of about 10,000 to 15,000, an isoelectric point of about 7 and a defined amino acid composition distinctly different from...
4770781 Purification of human interleukin-1 species  
Human interleukin-1 (IL-1) charged species (pI 6.8, 6.0, 5.4 and 5.2) are separated and purified by a rapid and efficient two or three stage chromatographic process. Interleukin-1 species present...
4766224 Purification and activation of proteins from insoluble inclusion bodies  
Purification and solubilization of proteins produced in transformant microorganisms as insoluble, biologically inactive inclusion bodies is effected by solubilizing the inclusion bodies in SDS;...
4765903 Purification of monomeric interferon  
Fast moving monomers of alpha-2 interferon ("IFN-alpha-2") are purified from slow moving monomers and oligomers of interferon and from noninterferon proteins using a combination of immunoaffinity...
4766205 Method for isolation of recombinant polypeptides in biologically active forms  
Disclosed are improved methods for orienting polypeptide molecules containing multiple disulfide bonds into their native conformation through (1) treating the polypeptide with (a) a denaturing...
4762617 Size-exclusion chromatography system for macromolecular interaction analysis  
A low pressure, microcomputer controlled system employing high performance liquid chromatography (HPLC) allows for precise analysis of the interaction of two reversibly associating macromolecules...
4758657 Method of purifying Factor VIII:C  
Disclosed is a process for purifying Factor VIII:C in high yield and potency from source material containing Factor VIII:C, Factor VIII:R and other plasma proteins and factors comprising the steps...
4753983 Polymeric matrix for affinity chromatography and immobilization of ligands  
A matrix useful for immobilizing organic ligands, such as biologically active materials, is prepared by reacting a hydroxyl group containing polymer with polyethyleneimine.
4746647 Purifying protein or peptide recombinant DNA products by electroseparation  
A method of purifying a contaminated product (protein/peptide) produced by rDNA technique, from hydrophobic contaminants which are charged and originate from the microbial cloning host employed,...
4740306 Chromatographic column  
A chromatographic column and process for isolating or purifying steroid hormone or cell membrane receptors using the column are provided in which the column contains at least three resin layers...
4738926 Method for purification of HBs antigen  
Industrially useful method for the purification of HBs antigen produced by a recombinant organism being capable of producing HBs antigen which is prepared by means of DNA recombination technique,...
4736020 Purification of hTNF  
The purification of hTNF by ion exchange chromatography is described.
4736019 Process for the separation of antifactor VIII:C antibodies, more particularly usable for the purification of the blood plasma of a type a hemophiliac  
The process for the separation of antiVIII:C antibodies present in a liquid consists of contacting said liquid with a solid support constituted by a polymer or a copolymer having in its chain...
4732683 Purification method for alpha interferon  
A process for the purification of human interferon alpha involving a three-step chromatography sequence under highly dissociating conditions is disclosed. The purification method involves a first...
4730036 Purifications of B-cell inducing factor (BIF) and B-cell growth factor (BGF)  
Highly purified T cell replacing factor (TRF or BIF) essentially free of IL-2 and Interferon activities is obtained in the invention. BIF is useful for treatment of immunoregulatory disorders...
4725673 Plasma fraction purification using silica resin bound to a ligand  
There is provided, in accordance with practice of this invention, a process for separating Factor IX and/or Factor X from an impure protein fraction containing protein in addition to Factors IX and...
4722999 Cyclophilin  
Homogeneous cyclophilin, a soluble binding protein, having a specific binding activity of above 50 ug cyclosporin A per mg protein and a molecular weight of about 17,600 daltons, reversibly binds...
4723000 Human interferon gamma and interleukin-2  
A process for producing unique human interferon gamma and interleukin-2 by chromatographic fractionation utilizing ion exchange and metal chelate chromatography. The interferon gamma and...
4721573 Use of sulfonic derivatives of acylated polyethyleneimine bonded phase silica products  
Sulfonic derivatives of N-acylated covalently bound, non-crosslinked polyethyleneimine bonded phase silicas of the formula: ##STR1## wherein is the backbone of a silica gel or glass, n is an...
4716219 Adsorbent for protein purification  
Adsorbents, which are suitable for the affinity chromatography of proteins, especially of interferons, and which consist of an electroneutral carrier matrix, --O--CH 2 --CH(OH)--CH 2 --NH- groups...
4710566 Purification of the messenger RNA cap-binding protein  
The synthesis of a new affinity medium, the p-aminophenyl-γ-ester of 7-methylguanosine-5'-triphosphate coupled to Sepharose, for use in affinity chromatography is claimed. An improved method in...
4707542 Immunogenic HbsAg derived from transformed yeast  
The surface antigen protein of human Hepatitis B virus is synthesized in Saccharomyces cerevisiae as a 23,000-26,000 dalton polypeptide, essentially free of intermolecular disulfide bonds. This...
4694074 Process for the purification of HBsAg  
A process for the purification of HBsAg is disclosed, which comprises adsorbing specifically on a carrier, in the presence of an inorganic salt in an amount of 5 to 25 W/V %, an HBsAg obtained by...
4687820 Modified polypeptide supports  
A modified polypeptide material comprising an insoluble polypeptide carrier and synthetic polymer, the synthetic polymer made from (a) a polymerizable compound which has a chemical group capable of...
4681761 Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine  
The major iron-regulated protein of a pathogenic species of the genus Neisseria, the gonococcal congener of which (MIRP) protein has a molecular weight of approximately 37,000 daltons and...
4680120 Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction  
The reaction product of silica gel or controlled pore glass and carboalkoxyalkyl silanes are suitable for use as packing in solid phase extraction columns for cleanup of urine samples for analysis...
4680121 Bonded phase of silica for solid phase extraction  
A bonded phase silica product of the formula: ##STR1## in which ##STR2## is the backbone of a silica gel or controlled pore glass, X is selected from --O--, --S--, ##STR3## each R and R 1 are each...
4677197 Purification method for tumor necrosis factor  
An improved method for purifying TNF, especially recombinantly produced TNF in bacteria, is disclosed. The purification employs a hydrophobic support in a chromatographic column which is then...
4675383 Purification of T-cell growth factor  
Substantially homogenous T-cell growth factor is isolated. A multiple-step purification procedure of T-cell growth factor-containing biological sample includes at least one reverse-phase HPLC...
4675384 Fractionation/purification of plasma by ion exchange chromatography  
The plasma proteins contained in a plasma solution thereof are chromatographically fractioned, e.g., to obtain a high purity therapeutic grade albumin product, by successively contacting said...
4667024 Process for the preparation of purified vancomycin class antibiotics  
A novel process for the isolation and purification of vancomycin class antibiotics which utilized affinity chromatography by the formation of a sorption complex between the antibiotic and an...
4667018 Process for the purification of proteins using acidic polysaccharide gels  
A process for the purification of proteins from a fluid medium wherein said proteins have an isoelectric pH higher than the pH of said fluid medium, said process comprising passing the liquid...